Rishi Surana, MD, PhD has been named the 2024 Fellow.
Dr. Surana grew up in Lawrence, KS and received his B.S. in Microbiology from the
University of Michigan—Ann Arbor. After a year conducting research as a Pre-doctoral
Cancer Research Training Award (Pre-CRTA) recipient at the National Cancer Institute,
he attended Georgetown University where he received his M.D. and Ph.D degrees as a
member of the combined M.D./Ph.D program.
After medical school, Dr. Surana completed his internship and residency in internal medicine at Oregon Health andScience University and subsequently completed his hematology/oncology fellowship at the University of Texas MD Anderson Cancer Center.
Dr. Surana joined the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute in 2022 as a medical oncologist and is also a member of the faculty at Harvard Medical School. Dr. Surana is an active clinical and translational researcher with a focus on understanding how the tumor microenvironment influences clinical outcomes and responses to various anti-cancer therapies. He sees patients with gastrointestinal cancers in his clinic and is involved in developing clinical trials to help improve upon and bring new therapies to our patients. Dr. Surana is also an active member of the Immune Effector Cell (IEC) program within Dana-Farber and works to bring novel cellular-therapy based clinical trials to patients with gastrointestinal malignancies.
In his spare time, Dr. Surana enjoys traveling, spending time with friends and family and rooting for his favorite sports teams.